RESUME
John S. Sundsmo, Ph.D.


MAIL: P.O. Box 927, Sausalito, CA. 94966
Tel: 760-994-7028
eMAIL:  jssund@gmail.com

 

 

Summary Overview:
PhD., Microbiology Immunology, University of Washington
Post-Doctoral, Molecular Oncology, Fred Hutchinson Cancer Research Center
Post-Doctoral, Protein Biochemistry and Enzymology, Scripps Research Institute
Staff Member, Molecular Immunology, Scripps Research Institute – complement and coagulation

BioPharmaceutical Industry, Senior Scientist to President and CEO in startup companies  

Patent Agent
Registered US Patent Agent.  #34,446. (1990)
Law Firm:
Christensen, O'Connor, Johnson and Kindness (Seattle, WA) -1990-1993
Weiss, Jensen, Ellis and Howard (Seattle, WA and Portland, OR) -1993-1995
Industry Intellectual Property:
Manager Technology Development, Viagene Inc. (Now Chiron) -1989-1990
Director, Intellectual Property, Cytran Corporation (closed). 1995-1996
Director, Intellectual Property, SIBIA Neurosciences, Inc. (Now Merck) -1997-1998
Founder and Director, Intellectual Property, Phage Therapeutics, Inc. (Bothell, WA) – 1996-2001
Private Practice dba BioMedPatent – 1998-present (Vista, CA and Sausalito, CA)
Clients including Phage Therapeutics, Inc. (Bothell, WA), RACE Pharmaceuticals, Inc. (Bothell, WA), International Medical Innovations (Birmingham, AL), Drug Risk Solutions, Inc. (Saratoga Springs, NY); Anomeric Inc. (Baton Rouge, LA); La Haye Laboratories (Redmond, WA) -1998-2007; TumorEnd (2009-present).


Most Recently:
President and Director of Intellectual Property, PrimeGen Biotech, LLC (Irvine, CA). 2007-2009.
Vice President R&D and Intellectual Property, Stellar Biotechnologies, Inc. [TSX: KLH] (Port Hueneme, CA). 2010-present – (Introduced by the NSF Innovation Accelerator)


Skills
Freedom-to-operate, infringement and competition analysis for business development
Patent and prior art searching and patentability analysis
Client counseling, strategy development and intellectual property tracking
Patent preparation US and Foreign – (including prophetic)
Patent prosecution US and Foreign –(including Interference and Opposition Practice)
Patent strategy development and implementation
Reviewing and assessing third party patents
Liaison with outside counsel on business and patent matters
Patent auditing and valuation for merger and acquisition
Litigation support (Federal Circuit, SIBIA v. Cadus Pharmaceuticals)
Trade Secret litigation support (sole expert witness; BioRad v. Triton Biosciences div. Shell Oil)
With counsel: MTAs, CDAs, term sheets and draft licensing terms, letters of intent, consulting agreements, scientific advisory board agreements, SCRO/ESCRO/IRB documents
Ghost writer scientific manuscripts, grant applications, business technical and website materials
Certified Medical Writer Professional (Regulatory) – CfPIE, 2009-2010.
SOPs, batch records, CMC section components, Q6B safety


NSF SBIR Peer Reviewer
Drug Discovery, Bioprocess Development and Medical Device Study Sections – 2009-present.


Areas of practice
Oncology (Rx/Dx); Protein biochemistry, immunochemistry, enzymology and purification; Stem Cell Biology (ESC, iPS cells), Molecular Biology (genetic markers, targets, nucleotide and amino acid sequence); Gene Transfer (retroviral vectors); Cell Biology (cell cycle); Molecular Immunology (anti-inflammatory agents); HTS assays; Diagnostic Assays and Devices (infectious diseases); Wound Healing; Parkinson’s (dopaminergic compounds); Alzheimer’s; Auto-Immune Disease (SLE/RA); Ophthalmology (ARMD); Pharmaceutical Chemistry (dopaminergic agents); Carbohydrate Chemistry (glycolipids); Methods of Administration and Delivery Formulations (cyclodextrin); Agricultural; Light Mechanical and Hydraulics; Electronics/Telecommunications; Business Methods; Bioinformatics; Research Reagents; Genetic Markers (SNPs); Intracellular Delivery (single walled nanotubes; lipids; cell penetrable peptides)

 

Illustrative Activities
Conducted initial infringement analysis, (with selected file wrapper analysis), comprising more than 1200 different stem cell patents to identify competition and paths to freedom to operate;
Developed first corporate business plan and patent strategy;
Streamlined and redirected ongoing patent prosecution to better define commercially viable inventions;
Redirected ongoing R&D activities to better capture niche IP and product market opportunities; and,
Drafted six provisional patent applications to sequentially capture emerging technology for: (i) germ line stem cells, (ii) adipose-derived stem cells, (iii) induced pluripotent stem (iPS) cells, (iv) molecular stem cell tools and (v) stem cell medical devices; and,
Managed and directed prosecution docket of US and international cases (32).

 

Patents and Applications (Inventor):
US 4,760,131. Sundsmo, J.S., G. Ksander, R. Ross, and J. McPherson.  Novel Wound Healing Composition.
EPA 243,179, AU 8,771,914; Sundsmo et al. Soft Tissue Wound Healing Composition Comprises Fibrillar Collagen, Heparin, or Heparin-like Glycosaminoglycan and Chemotactic, Growth or Differentiation Factor.
JP63054328 (A). Sundsmo, J.S., Ksander, G.A. et al. Wound Healing Composition and Wound Bandage Therewith.
AU7191487. Sundsmo, J.S., Ksander, G.A. et al. Wound Healing Composition and Wound Dressing Containing It.
AT81780 (T). Sundsmo, J.S., Ksander, G.A. et al. Wundeheilende Zusammensetzung.
US 6,478,750. Morrison, J.F., Morrison, P.A., Selavka, C.M., Eden, T.M., Thuss, C.B., Hopper, K.C., Sundsmo, J.S. Hair Collection Device for Drug Testing. (author and inventor)
US7345031 (B2). Christian, S. and J. Sundsmo. Pharmaceutical DopamineGlycoconjugate Compositions and Methods of Their Preparation and Use. (author and inventor)
US 20020198748. Eden, T. and J. Sundsmo. System and method for implementing an employee-rights-sensitive drug free workplace policy. (author and inventor)
US 20050037386 WO2005039381 (A2).  Morrison, J.F., Sundsmo, J.S., Selavka, C.M., Brill, D.H. Composition and Processes for Analysis of Pharmacologic Agents in Biological Samples. (author and inventor)
US20050250739. Christian, S. and J. Sundsmo. Pharmaceutical DopamineGlycoconjugate Compositions and Methods of Their Preparation and Use. (author and inventor)
WO 2009032456 (A2) Kannemeier, C., Marh, J.S.W., Howerton, K., Sundsmo, J.S. Non-Viral Delivery of Transcriptional Factors that Reprogram Human Somatic Cells into a Stem Cell-Like State.  (author and inventor)
WO 2009140655 (A1) Kannemeier, C., Pham, J., Javier, C., Sundsmo, J.S. Methods for Efficient Viral Reprogramming of Somatic Cells into Stem Cell-Like Pluripotent Cells. (author and inventor)

 

Continuing Education:
FDA-Regulatory Affairs: preIND-Overview:UCSD Extension, Three Day for credit course- Q2/ 2001 (passed); cGLP:  UCSD Extension, Three Day for credit course- Q2/ 2001 (passed)
Certification Program: Medical Writer Professional, Regulatory – 2009-2010 (certified)

 

Representative Examples of Assistance Rendered: (Appendix A) – next pages
Scientific Publications (Appendix B) – available upon request


Appendix A
Examples Of Intellectual Property Assistance Rendered


Light Mechanical and Hydraulics:
US 5,871,109. Litten, G.L. Railcar Cushion Device Preload Valving Systems.
US 5,826,735. Litten, G.L. Railcar Cushion Device Valving Systems.
US6,024,413, Spencer, B. et al. Metal Matrix Composite Bicycle Rims. Spencer, B.
US 5,829,947. Litten, G.L. Cargo Handling Hydraulic Ramp Loader System and Methods.
US 5,611,570; US 5,722,688. Garcia, R.R. Unibeam Trailer Chassis.
US 6,478,750. Morrison, J.; Sundsmo, J.S. et al. Hair Collection Device and Methods of Use
Gene Transfer:
US 5,716,826. Gruber, H.E., Jolly, D.J., Respess, J.G. and P.K. Laikind. Recombinant Retroviruses.
US 5,691,177. Gruber,H.E., Jolly, D.J., Respess, J.G. and P.K. Laikind. Recombinant Retroviruses Expressing a Protein That Converts a Pro-Drug Into a Cytotoxic Drug.
US 5,662,896. Barber, J.R., Jolly, D.J., Respess, J.G. Compositions and Methods for Cancer Immunotherapy.
US 5,716,832. PCT/US 91/06852. Barber, J.R., Jolly, D.J., Respess, J.G. and S.M.W. Chang. Packaging Cells.
US 5,716,613. Gruber,H.E., Jolly, D.J., Respess, J.G. and P.K. Laikind. Recombinant Retroviruses.
US 5,470,726. Miller, A.D., Garcia-Martinez,J.V., Eiden, M.V. and C.A. Wilson. Retrovirus Packaging and Producer Cell Lines Based on Gibbon Ape Leukemia Virus.
US 5,219,740. Miller, A.D. and T.D. Palmer. Retroviral Gene Transfer Into Diploid Fibroblasts For Gene Therapy.
Cell Biology/ Drug Screening Assays:
US 5,645,999. Roberts, J.M., Otsubo, M., Koff, A.C. and F. Cross. Assays for Compounds That Modulate or Alter Cyclin E Activity.
US 5,693,487. Blackwood, E.M. and R.N. Eisenman. Nucleic Acids Encoding Max: A Helix-Loop-Helix Zipper Protein That Forms a Sequence Specific DNA-Binding Complex With Myc and Mad.
US 5,499,755. PCT/US 92/07866. Roberts, J.M. , Ohtsubo, M., Koff, A.C. and F. Cross. Human Cyclin E. US5,499,755.
PCT/US 93/04458. Plon, S.E., Groudine, M.T. Hartwell, L.H. and T.A. Weinert. Human cell Cycle Checkpoint Genes.
US 5,302,519. Blackwood, E.M. and R.N. Eisenman. Methods of Producing Mad polypeptide.
PCT/US 92/07629. Blackwood, E.W., R. Ayer and R. Eisenman.  MAX: A Helix-Loop-Helix Zipper Protein That Forms a Sequence Specific DNA-Binding Partner With Myc and Mad.

 

Assays (continued):
US 5,466,576. Schultz,V.P. and V.A. Zakian. Modulation of PIF-1-Type Helicases.
PCT/US 92/02087. Mathison, L., Soliday, C.L. and J.A. Rambosek. Isolation and Sequence of the Acetyl CoA: Deacetylcephalosporin Acetyltransferase Gene.
Agricultural:
US 5,256,425. Herman, R.E., Ware, D.R. and J.E. Clarke. Antibiotic Resistant Strain of Lactobacillus acidophilus.
US 5,179,020. Herman, R.E., Ware, D.R. and J.E. Clarke. Antibiotic Resistant Strain of Lactobacillus acidophilus.
Drug Delivery:
US 5,180,716. Yaksh, I.  Cyclodextrin Complexes for Neuraxial Drug Delivery.
Diagnostic Devices and Assays:
US 5,328,848. Fong, C.T.O., Ali Elmesai, M.R. and B.Q. Fieggen.  Method for Hydrating and Calibrating a Sterilizable Fiber-Optic Catheter.
US 5,861,259. Roberts, J.M., Ohtsubo, M., Koff, A.C. and Cross., F. Immunoassays for human cyclin E.
US 5,935,804; US 6,090,573.. Laine, R.A. and W.J. Lo. Method for detecting eubacteria in biological samples with catalytically inactive murein binding enzymes.
US 6,093,552. Laine, R.A. et al. Diagnosis of fungal infections with a chitinase
US 6,159,719. Laine, R.A. et al. Pan-Bacterial and Pan-Fungal Identification Reagents and Methods of Use
US 6,184,027. Laine, R.A. et al. Isolation and Purification of Eubacteria and Fungus with Catalytically Inactive Murein Binding Enzymes
PCT/US98/05580.  Laine, R.A. and W.J. Lo. Pan-Bacterial and Pan-Fungal Identification Reagents and Methods of Use
20050037386. Morrison, J.F., Sundsmo, J.S., et al. Composition and Processes for Analysis of Pharmacologic Agents in Biological Samples

Electronics/Telecommunications:
PCT/US96/09594, WO96/41448. Walsh, J. Handheld Remote Computer Control and Methods for Secured Interactive Real‑Time Telecommunications.
PCT/US96/09407, WO96/41447. Walsh, J. Low Power Telecommunication Controller for a Host Computer Server.
Pharmaceuticals:
US 6,548, 484. Christian, S.T. Pharmaceutical dopamine glycoconjugate compositions.
US 6,361,806. Allen, M. Composition for and Method of Effecting Changes in Subcutaneous Adipose Tissues.
WO92/17191; WO93/08815; US 5,538,951; US 5,902,790. Green, L. et al. Pharmaceutical Tryptophane Containing Compounds, Compositions and Methods of Use Thereof. 
WO94/09804; WO93/08816; WO03/12810.  Green, L. et al. Pharmaceutical Lysine Containing Compounds, Compositions and Methods of Use Thereof.
US 6,777,195. Kozhemyakin et al.  Pharmaceutical Dipeptide Compositions and Methods of Use: Immunostimulants
CA 2,056,723; CA 2,056,800; CA 2,109,796. Bianco, J. et al. Use of Xanthines for the Preparation of Medicament Having Immunosuppressing Activity
US 5,620,962. Winget, R. Anti-Inflammatory Compositions Containing Monogalatosyl Diecosapentaenoyl Glycerol and Methods Relating Thereto.
PCT/IB 94/00192. Khavinson,V.K., Sery, S.V., Kozhemyakin, A.L. and R.I. Valeyev. Compositions and Methods for Treatment and Prevention of Retinal Dysfunctions.
US5,633,357. Tius, M.A. and M.R. Hagedone. Synthesis of Carboxylic Acid Glucuronides
US 5,292,899. Tius, M.A. and M.R. Hagedone. Synthesis of 11-nor-Delta-9-tetrahydrocannabinol-9-carboxylic Acid Glucuronide.
US 5,814,611; US 5,538,951; US 5,674,851. Morozov, et. al. Pharmaceutical Preparation for the Therapy of Immune Deficiency Conditions.
US 5,811,399; US 5,807 830; US 5,789,384; US 5,770,576. Khavinson, et. al. Pharmaceutical Dipeptide Compositions and Methods of Use Thereof
Biologics:
09/xxx.xxx Sundsmo, Chanischvili, et al. Therapeutic Bacteriophage, Methods of Production and Methods of Use Thereof (1997; Docket No. pa001).
09/xxx,xxx Sundsmo, J.S. et al. Therapeutic Staphylococcal Bacteriophage, Methods of Production and Methods of Use Thereof (1997; Docket No. pa002).
09/xxx,xxx Sundsmo, J.S. et al. Therapeutics Bacteriophage, Methods of Production and Methods of Use Thereof (1997; Docket No. pa003).
09/xxx,xxx Sundsmo, J.S. et al. Therapeutics Staphylococcal Bacteriophage, Methods of Production and Methods of Use Thereof (1998; Docket No. pa004)
Biologics (continued):
10/xxx,xxx Sundsmo, J.S. et al. Therapeutic Bacteriophage, Methods of Preparation and Methods of Use Thereof (2001; Docket No. pa005)
10/xxx,xxx Sundsmo, J.S. et al. Therapeutic Bacteriophage, Methods of Preparation and Methods of Use Thereof (2001; Docket No. pa006)
10/xxx,xxx Sundsmo, J.S. et al. Therapeutic Bacteriophage, Methods of Preparation and Methods of Use Thereof (2001; Docket No. pa007)
10/xxx,xxx Sundsmo, J.S. et al. Therapeutic Bacteriophage, Methods of Preparation and Methods of Use Thereof (2001; Docket No. pa008)
20020198748. Christian, S.T. Novel pharmaceutical agents containing carbohydrate moieties and methods of their preparation and use
20030119761. Christian, S.T. Novel pharmaceutical anti-infective agents containing carbohydrate moieties and methods of their preparation and use
20050250739. Christian, S.T. and J.S. Sundsmo. Pharmaceutical dopamine glycoconjugate compositions and methods of their preparation and use
WO 2009032456 (A2) Kannemeier, C., Marh, J.S.W., Howerton, K., Sundsmo, J.S. Non-Viral Delivery of Transcriptional Factors that Reprogram Human Somatic Cells into a Stem Cell-Like State.  (author and inventor)
WO 2009140655 (A1) Kannemeier, C., Pham, J., Javier, C., Sundsmo, J.S. Methods for Efficient Viral Reprogramming of Somatic Cells into Stem Cell-Like Pluripotent Cells. (author and inventor)
Immunology/ Anti-Inflammatory Agents/ Cell Adhesion:
PCT/US 90/04978. Wayner, E. Inhibition of Lymphocyte Adherence to Vascular Endothelium.
US 5,177,015; US  Matsuura, S. and S.I. Hakomori. Onco-Developmentally Regulated Alpha N-Acetylgalactosaminyltransferase.
US 5,300,630; US 5,243,029. Matsuura, S. and S.I. Hakomori. Oncofetal Fibronectin Epitope.
Wound Healing Composites:
4,760,131. Sundsmo; J. S. et al. Wound-Healing Composition
Electronic Business Processes:
20020198748. Eden, T.M. and J.S. Sundsmo. System and Method for Implementing an Employee-Rights-Sensitive Drug Free Workplace Policy.
Alzheimer's Disease:
US 5,499,604. Schellenberg,G.D., Bird, T.D. and E.M. Wijsman. Chromosome 14 and Familial Alzheimer's Disease Genetic Markers and Assays.